TGA announces more medicine shortages are now impacting Australia  The Therapeutic Goods Administration (TGA) is advising health professionals and consumers that there is an ongoing shortage of medicines containing olmesartan or prazosin as the sole active ingredient. In order to reduce the impact of these shortages, the TGA has issued Serious Shortage Substitution Notices for